Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fendrix versus double-dose Engerix B in HIV-infected hepatitis B vaccine non-responders
2014-002112-16Phase 2Unknown
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Hepatitis B vaccine and hepatitis B vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoints: Hepatitis B surface antibody titre and Seroconversion rate above protective threshold. Status: unknown.
02
Drugs
Hepatitis B vaccinehepatitis B vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2014-002112-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002112-16.